EP1877070
THERAPEUTIC USE OF TGF-BETA2 ANTISENSE OLIGONUCLEOTIDES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.5.2006EP published:
31.12.2008EP application number:
06755024.4
EPO information:
European Patent Register
Max expiry date:
3.5.2026
Title:
THERAPEUTIC USE OF TGF-BETA2 ANTISENSE OLIGONUCLEOTIDES
Timeline
Today
4.5.2006EP application
31.12.2008EP Publication
Owner
Name:
Antisense Pharma GmbHAddress:
Josef Engert Strasse 9, 93053, Regensburg, DE
Inventor
Name:
SCHLINGENSIEPEN, Karl-HermannAddress:
Donaustauf, DE
Name:
SCHLINGENSIEPEN, ReimarAddress:
Regensburg, DE
Priority
Number:
05009802Date:
5.5.2005Country:
EP
Number:
680493 PDate:
13.5.2005Country:
US